Compare General Mills, Inc. (GIS) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
General Mills, Inc. vs Nuwellis Inc — how do they compare? General Mills, Inc. trades at $32.43 (market cap $17.43B), while Nuwellis Inc trades at $0.69 (market cap $2.20M). The key difference: General Mills, Inc. is far larger — about 7922.7× Nuwellis Inc's market cap, and General Mills, Inc. pays a 7.49% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold General Mills, Inc. for 106 Days and Nuwellis Inc for 26 Days on average.
| GIS | NUWE | |
|---|---|---|
Market Cap | $17.43B | $2.20M |
Volume | 16,554,362 | 121,544 |
Sector | Consumer Staples | Health |
52-Week High | $49.36 | $146.65 |
52-Week Low | $31.67 | $0.68 |
Typical Hold Time | 106 Days | 26 Days |
Enterprise Value | $30.61B | -$1.52M |
Dividend Yield | 7.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
General Mills (GIS) trades at $31.77, down 1.27% on the day, with a bearish technical signal and mixed earnings performance. The stock shows attractive valuation ratios like a P/E of 9.23 and P/S of 0.93, but profitability metrics are weak with a negative net income margin and ROE. Recent news highlights a CEO transition and a 22% stock decline last month amid revenue and profit pressures.
The outlook is cautious; while the dividend yield is appealing and cost-saving initiatives are in place, declining revenue, margin compression, and high debt levels pose significant risks. Analyst consensus is mixed with a $36 price target, but bearish sentiment and competitive pressures suggest limited near-term upside.
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About General Mills, Inc.
General Mills is a leading global packaged food company that produces snacks, cereal, convenient meals, yogurt, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Yoplait, Pillsbury, Betty Crocker, BLUE, and Haagen-Dazs. In fiscal 2022, 77% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. While most of General Mills' products are sold through retail stores to consumers, the company also sells products into the food-service channel and the commercial baking industry.
Read more on GIS →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
